References: 1. http://www.satyamevjayate.in/issue04/learnmore/detail/19/ 2. http://www.indicine.com/movies/bollywood/satyamev-jayate-episode-4-with-subtitles-watch-online/ 3. http://m.theglobeandmail.com/news/world/drug-companies-watching-indias-drug-patent-case/article534381/?service=mobile 4. http://www.safemedicinesindia.in/government18.php 5. http://www.thehindu.com/health/policy-and-issues/follow-professional-ethics-doctors-urged/article3520828.ece 6. http://www.frost.com/prod/servlet/market-insight-print
Premium Medicine India Developing country
commercial success. However‚ in the market like India and also other competitive markets like all emerging markets where high competitiveness exists‚ speed to market with newness either for patented or generic products can bear rewards. It’s also equally true that in markets like India where 2 more generics and competitive brands are available‚ it is difficult to reward investment. As a result‚ it is really important to develop a strategic balance between older brands might not have even matured
Premium Pharmaceutical industry Vitamin D Calcium
companies have a large chunk of their revenues coming from exports. While some are focusing on the generics MARKET in the US‚ Europe and semi-regulated markets‚ others are turning their attention to custom manufacturing for innovator companies. Biopharmaceuticals is also increasingly becoming an area of interest given the complexity in manufacture and limited competition. Market Size India ’s drugs and pharmaceuticals industry is expected to grow at a compound annual growth rate (CAGR) of 14 per
Premium Pharmaceutical industry Generic drug Pharmacology
marketing drugs‚ thus charging high prices enables for cost of capital recovery and profit generation. 2. Patent related and Generic Competition: The developed countries like US and Europe have strong patent protection laws which gives a lot of benefits for the pharmaceutical companies. But‚ the patent laws in other countries are not strong enough and thus they face a risk of loss. 3. Counterfeit Drugs: Some developing countries have weak regulations when it comes to counterfeit drugs from generic
Premium Pharmaceutical industry Pharmacology Generic drug
8 APPENDIX 2 9 REFERENCES 10 INTRODUCTION The origin of the modern pharmaceutical industry can be traced to the late 19th century. There are five broad types of industry players: Ethical‚ Generic‚ Biotech‚ OTC‚ and Vaccine companies. Ethical drug is key sector with 80% of market share by value and 50% by volume. Key markets are USA‚ Japan‚ The EU‚ China‚ and Mexico. Companies with consistently high levels of R&D spending and productivity have become industry leaders
Premium Strategic management Pharmaceutical industry Generic drug
|[pic][pic] | |Pfizer-Wyeth Merger Analysis | | | |“Creation of the World’s Premier Biopharmaceuticals Company”
Premium Generic drug Pharmaceutical industry
Sometimes described as Frankenstein’s Monster‚ Pfizer has been aggressively swallowing up smaller companies since the early 1990’s to become the present day drug giant. Pfizer along with other companies will be facing a fork in the road in the near future as they exit their blockbuster growth with the expiration of many of the company’s most successful drug patents. In this paper we will conduct several analyses to identify strategies that would be viable options for the company. Pfizer‚ which has been a
Premium Corporate governance Board of directors Pharmaceutical industry
Company worth Analysis 34 Annual Objectives: 35 Strategic Review and Evaluation Procedures: 35 Bibliography: 36 Executive Summary: Merck & Co. is a research driven pharmaceutical company involved in manufacturing of pharmaceuticals and drugs. Merck ’s products are not limited to preventive and therapeutic vaccines. Merck merged with Schering-Plough in November of 2009 for $41billion. Merck is based in Whitehouse Station‚ New Jersey and has more than 110000 employees. The company has
Premium Revenue Financial ratios Generic drug
TEVA) $6.8Bn acquisition of Cephalon‚ Inc. (NASDAQ: CEPH) – October 14‚ 2011 | Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company which develops‚ produces and markets affordable generic drugs. Teva is the world’s largest generic drug maker‚ with a direct presence in about 60 countries. Teva’s branded businesses focus on neurological‚ respiratory and women’s health therapeutic areas as well as biologics. | FINANCIAL FIGURES $Mn | Teva | Cephalon | Market
Premium Generic drug Takeover Pharmaceutical industry
industry of India has matured over the years into a major producer of bulk drugs‚ rated among the top five in the world. The industry is largely concentrated in the production of ‘generics’ on account of the Process Patent Law introduced in the seventies (repealed under the recent TRIPS Agreement). India has since been able to establish technological capability for manufacture and supplying of generic drugs. This ‘generics capability’ of India has attracted worldwide attention. A noticeable surge
Premium Pharmaceutical industry International trade Generic drug